{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"48"}],"units":"Participants"}],"description":"Determine the number of participants who experience Serious Adverse events while on sunitinib malate study.","groups":[{"description":"Sunitinib malate, 50 mg daily, for 4 weeks every 6 weeks","id":"OG000","title":"Experimental: Sunitinib Malate (SU011248) Treatment"}],"paramType":"NUMBER","populationDescription":"All Participants","reportingStatus":"POSTED","timeFrame":"4 years, 7 months","title":"Number of Participants With Serious Adverse Events (SAEs)","type":"SECONDARY","unitOfMeasure":"participants"}